<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="719">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05151796</url>
  </required_header>
  <id_info>
    <org_study_id>ulganescardio_aspirine</org_study_id>
    <nct_id>NCT05151796</nct_id>
  </id_info>
  <brief_title>Continuation of Aspirin Before Isolated Heart Valve Surgery</brief_title>
  <official_title>Effect of Continuation of Aspirin Before Isolated Heart Valve Surgery on Postoperative Bleeding and Transfusion: a Single-center Retrospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Liege</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Liege</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Whether or not continuing aspirin up to de day before surgery increases the risk of bleeding&#xD;
      and/or prevents thrombo-embolic complications remains debated. The investigators&#xD;
      retrospectively investigated the whether continuing aspirine within 5 days of isolated heart&#xD;
      valve surgery increased the risk of bleeding.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2012</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Actual">May 1, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The number of units of packed red blood cells transfused anytime during the hospital stay</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Chest tube drainage</measure>
    <time_frame>24 hours</time_frame>
    <description>volume of chest tube drainage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical revision for bleeding</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any thrombo-embolic complication</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transfusion of any type of blood product</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Isolated Heart Valve Surgery</condition>
  <arm_group>
    <arm_group_label>Aspirin continued within 5 days before surgery</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Aspirin discontinued more than 5 days before surgery</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aspirin</intervention_name>
    <description>Daily aspirin intake for cardiovascular prevention</description>
    <arm_group_label>Aspirin continued within 5 days before surgery</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients undergoing isolated heart valve surgery at the University Hospital of Liege&#xD;
        (Belgium)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Isolated heart valve surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Antiplatelet agent other than aspirin or anticoagulant not discontinued preoperatively&#xD;
&#xD;
          -  Emergent or salvage surgery&#xD;
&#xD;
          -  Surgery for endocarditis&#xD;
&#xD;
          -  Use of NSAIDs within 48 hours before surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Vincent Bonhomme, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>CHU of Liège</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gregory Hans, MD</last_name>
    <email>G.Hans@chuliege.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU of Liege</name>
      <address>
        <city>Liège</city>
        <state>Liege</state>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gregory Hans, MD, PhD</last_name>
      <email>G.Hans@chuliege.be</email>
    </contact>
    <contact_backup>
      <last_name>Alan Houben, MD</last_name>
      <email>ahouben@student.uliege.be</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 5, 2021</study_first_submitted>
  <study_first_submitted_qc>November 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 9, 2021</study_first_posted>
  <last_update_submitted>November 25, 2021</last_update_submitted>
  <last_update_submitted_qc>November 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Liege</investigator_affiliation>
    <investigator_full_name>Jean François Brichant</investigator_full_name>
    <investigator_title>Professor of Anesthesia</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

